Preterm Birth And PROM Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

Industry Outlook

The preterm birth and PROM testing market is set to reach from US$ 996.3 Mn in 2020 to US$ 1,201.2 Mn by 2020 representing slow growth at a compounded annual growth rate (CAGR) of 2.1% during the forecast period from 2021 to 2029. As per the research findings of World Health Organization (WHO), annually 15 million babies are born before the completion of 37 weeks of normal pregnancy and as a result approximately 1 million children die every year due to complications associated with preterm births.

Excellent diagnostic accuracy and sensitivity will increase the popularity of biomarkers as PROM testing kits

Physicians investigate preliminary symptoms such as vaginal bleeding, vaginal discharge, pelvic pressure etc., to confirm preterm birth complications. Pelvic examination is the first line of diagnostic approach which is performed several times over a period of time to study the contraction and changes of cervix. If the cervix begins to soften, dilate and become thin before 37 weeks of pregnancy the patient is diagnosed with preterm labor. Biomarkers such as Alpha-fetoprotein test (AFT), insulin like growth factor binding protein-1 (IGFBP-1), placental alpha macroglobulin-1 (PAMG-1) etc., are gaining tremendous attention in the last decade. Excellent diagnostic accuracy and sensitivity increases the popularity of biomarkers as PROM testing kits.

Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region

In the present scenario North America is leading the regional segment for preterm birth and PROM testing market with a share of 36%. Annually 3.9 million babies are born in North America of which 12.0% are born prematurely. Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region. Existence of major players such as Abbott Laboratories, Inc., CooperSurgical, Inc., Qiagen, Inc., Hologic, Inc. etc. further propel the market growth in North America region. Europe is the second largest market with a share of 28% on account of supportive regulatory environment provided by the European Medical Agency (EMA) for PROM testing kits and establishment of well-developed healthcare infrastructure. Asia Pacific currently holds 15% market share and will be showcasing rapid growth in the near future owing to increasing complication related to pregnancy and proactive government initiatives to provide optimum maternal care.

Historical & Forecast Period

This research report presents the analysis of each segment from

2019 to 2029

considering

2020

as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from

2021 to 2029

.

Report Scope by Segments

The market is segmented by test type and by geography.

By Test Type (2019-2029; US$ Mn)

• Pelvic Exam
• Ferning Test
• Nitrazine Test
• Pooling Test
• Ultrasound Test
• Uterine Monitoring Test
• Biomarkers

Geography Segment (2019-2029; US$ Mn)

• North America (U.S., Canada)
• Europe (U.K., Germany, Rest of Europe)
• Asia Pacific (China, Japan, Rest of APAC)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (GCC, Rest of the Middle East and Africa)

Biopharmaceutical companies specializing in manufacturing preterm birth and PROM testing kits are Abbott Laboratories, Inc., Biosynex, Clinical Innovations, LLC, CooperSurgical, Inc., Hologic, Inc., IQ Products, Medixbiochemica, NX Prenatal, Inc., Qiagen N.V. and Sera Prognostics, Inc.

Key questions answered in this report

• What will be the market assessment for preterm birth and prom testing market?
• What are the major symptoms associated with preterm labor and premature ruptures of membranes?
• Which major biopharmaceutical companies are actively engaged in the production of PROM testing test?
• What is the significance of pelvic examination during preterm labor?
• Which factors are responsible for the popularity of biomarkers as a diagnostic kit during for PROM?
• What is the current share of North America and its performance in the near future?

This product will be delivered within 2 business days.